niacin random control trial wax-matrix sustained-releas niacin hypercholesterolemia male femal subject year low-dens lipoprotein cholesterol valu percentil random double-blind studi new form niacin enduracin wax-matrix vehicl sustain releas niacin treatment group daili dose mg placebo- diet-treat control side-effect profil optim rang efficaci group mg signific reduct valu low-dens lipoprotein cholesterol total cholesterol total cholesterol-high-dens lipoprotein cholesterol ratio diet- placebo-tr control smaller improv high-dens lipoprotein cholesterol triglycerid level blood chemistri monitor reduct low-dens lipoprotein cholesterol level increas baselin level enzym niacin-tr subject improv side-effect profil wax-matrix form niacin notabl dropout rate due effect good medic complianc 